RxDoctor Payments Data

Robert Jackson, MD

Neurological Surgery · Laguna Hills, CANPI 1023003605

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $12,237 of the $17,571 with a category attached, or 69.6%. 32 manufacturers reported payments, led by Globus Medical at 44.1% of the total. 2025 is the largest year on record at $6,023, 2.6 times the $2,323 reported in 2019.

$17,571in general payments, 2019–2025

Across 152 payments — averaging $115.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$8K
  • Biogennix, LLC$6K
  • Orthofix Medical, Inc.$1K
  • Medtronic$486
  • Abbott$283
  • Si-bone, Inc.$127
  • plus $1K from 26 others
$134,088in research payments, 2019–2025

Across 27 payments — averaging $4966.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spineart USA Inc$76K
  • Medtronic$37K
  • Spineart SA$21K

What the payments were for

  • Royalty or licence$12,23770%
  • Consulting fees$1,3928%
  • Travel & lodging$180%
  • Food & beverage$3,92422%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,571 in reported general payments places this provider in the 70th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California →

Medicare billing

Part B allowed, 2024
$455,580
Medicare patients
429
Services billed
1,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin39$277
Celecoxib12$175
Meloxicam25$40

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Laguna Hills

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →